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Q: What is negative pressure wound therapy?
A: Negative pressure wound therapy (NPWT) is an adjunctive
wound treatment that involves the application of a controlled
level of subatmospheric pressure to a wound at 50 mm Hg to
175 mm Hg.1 Generated by a portable programmable pump, the
suction effect is applied to the entire interior surface of a clean
wound through open-cell polyurethane or polyvinyl alcohol
(PVA) foam.2 The polyurethane foam is black and has a pore
size of 400 µm to 600 µm, and the PVA foam is white and has a
pore size of 200 µm to 300 µm.
The foam dressing must be packed in the wound cavity so
that it has contact with the entire base, sidewalls, and undermined and tunneled surfaces. If more than 1 piece of foam is
needed, each additional piece must make contact with another
piece to ensure that the suction effect is distributed to all wound
surfaces. The dressing is then secured in the wound by covering
it with a semiocclusive polyurethane film drape supplied with
the device. The film drape should also cover at least 4 cm of surrounding intact skin.
The suction effect of the device is exerted on the foam dressing via a polyvinyl tube that is inserted into the foam through a
slit made in the vapor-permeable film drape. Care must be
taken to create an airtight seal where the tube passes through
the slit in the drape by pinching an additional strip of semipermeable film around the tube. The opposite end of the polyvinyl
tube is then connected to a tube that leads to a 300 cc canister
that is inserted into a recess in the vacuum pump. The disposable canister serves as a collection depot for edema fluid that is
suctioned from the wound tissue.
Q: NPWT is indicated for what types of wounds?
A: In 1995, the Food and Drug Administration (FDA) approved
NPWT for the treatment of nonhealing wounds. In January
2000, the FDA expanded the indications for NPWT to include
chronic, acute, traumatic, subacute, and dehisced wounds; diabetic ulcers; pressure ulcers; flaps; and grafts. Table 1 lists examples of patients with wound types for which NPWT may be
appropriate.
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Q: When would NPWT be contraindicated?
A: NPWT is contraindicated3 when:
• wounds contain necrotic tissue
• osteomyelitis is untreated
• fistulas to body cavities or organs are present
• malignancy is present in the wound
• treatment would place the foam dressing directly over arteries
and veins that are exposed in the wound.
NPWT should be used with caution3 on patients when there
is active bleeding in the wound, when hemostasis is difficult following debridement, or when anticoagulant therapy is used.
Q: Why is NPWT thought to be effective in managing
wounds?
A: Several research studies and clinical trials have demonstrated positive effects of NPWT on wound healing. Three experimental studies—2 on porcine models4,5 and 1 on humans6—
have provided evidence that NPWT enhances granulation tissue formation, clears edema fluid and bacteria from wounds,
and increases cutaneous perfusion and oxygen tension. Other
experimental studies have provided evidence that mechanical
stress—in the form of stretching or expansion applied to tissues
and cells (which likely occurs with NPWT)—induces a wide
variety of cells to proliferate in vivo (nerve, blood vessels, skin)
and in vitro (endothelial and vascular smooth muscle cells and
fibroblasts).7-11 In addition, 9 studies involving human subjects
have reported favorable outcomes following the use of NPWT
to promote closure of a variety of wounds. Of these 9 studies, 4
were noncontrolled case series,6,12-14 3 were individual case
studies,15-17 and 2 were small randomized controlled trials.17,18
Four of these studies reported significant increases in granulation tissue formation,1,12,14,18 while other studies reported significantly faster progress toward wound closure or improved
skin grafting outcomes.6,15,16 One study of 10 diabetic foot
wounds reported a clinically significant decrease in the size of
wounds treated with NPWT compared with wounds treated
with saline-moistened gauze.19
Q: Are different wounds managed differently with NPWT?
A: The NPWT protocol for management of a wound depends
WWW.WOUNDCAREJOURNAL.COM
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Table 1. EXAMPLES OF INDICATIONS FOR NPWT
Types of Wounds/Patient History
A 37-year-old woman is a type 1 brittle diabetic with digits of both
hands (except left thumb) auto-amputated secondary to gangrene
and both legs surgically amputated below the knee secondary to
gangrene. She is totally dependent on her husband for mobility. A
clean sacral pressure ulcer has deteriorated from 6.5 x 5.3 x 2.2 cm to
13.2 x 6.4 x 3.3 cm during 8 weeks of standard care. The wound is
undermined 2 to 5 cm along both margins of the wound’s long axis.

Rationale for Use
Eight weeks of standard care failed to promote healing of a wound
that has become life-threatening. NPWT has been documented to
increase the rate of granulation tissue formation1, 2,3 and epithelialization4 secondary to increasing perfusion to the wound bed.1 For
this wound, NPWT would be applied via a polyurethane sponge in
continuous mode at 125 mm Hg for the first 48 hours, after which
NPWT would be applied in the intermittent mode at 125 mm Hg.
The sponge dressing is changed every 48 hours.4

A 56-year-old man has bilateral lower extremity arterial occlusive disease and a chronic wound secondary to arterial insufficiency on the
lateral, middle third of his right leg. Ankle-brachial indexes are 0.5 on
the right and 0.6 on the left lower extremity. Transcutaneous oxygen
level of the hypoxic periwound skin is 28 mm Hg. The wound has
failed to show evidence of healing after 4 weeks of standard moist
wound care plus HBO therapy. The wound measures 8.3 x 5.5 x 3.7
cm (2.2 cm of fibula exposed). Twenty-five percent of the wound bed
is covered with yellow adherent necrotic tissue.

Four weeks of standard moist wound care plus HBO failed to promote measurable evidence of healing in this wound. NPWT has been
shown to maintain a moist wound environment,1 produce a 4-fold
increase in blood flow,1 and increase the rate of granulation tissue
formation.1,2,3 Following debridement and hemostasis, the exposed
bone would be covered with a nonadherent dressing. NPWT would
then be applied via a polyurethane sponge in the continuous mode
at 50 to 75 mm Hg, with sponge dressing changes every 48 hours.4

A 29-year-old man suffered traumatic amputation of his right upper
extremity at midforearm in a farm accident. Five weeks following surgical closure of the amputation stump, the wound dehisced and
became infected and edematous. The infection was treated with
antibiotic therapy, and the patient’s physician recommended concurrent adjunctive treatment with NPWT to facilitate healing by edema
removal and reduction of the bacterial burden.

NPWT has been shown to evacuate the localized edema fluid1 that
typically accumulates in the interstices surrounding a wound. It is
thought that the stagnated edema fluid compresses microvascular
and lymphatic vessels that, respectively, obstruct arterial delivery of
oxygen and the removal of bacteria.4 The edema fluid harbors bacteria and matrix metalloproteinase,5 releasing enzymes that break
down collagen secreted by fibroblasts. By evacuating the edema
fluid, circulation is restored and the bacterial burden is significantly
reduced, allowing healing to advance.1

1. Morykwas MJ, Argenta LC, Shelton-Brown E, McGuirt W. Vacuum assisted closure: a new method for wound control and treatment: animal studies and basic foundation. Ann Plast Surg 1997;38:553-62.
2. Mullner T, et al. The use of negative pressure to promote healing of tissue defects: a clinical trial using the vacuum seal technique. Br J Plast Surg 1997;50:194-9.
3. Joseph E, et al. A prospective randomized trial of vacuum assisted closure versus standard therapy of chronic non-healing wounds. Wounds 2000;46:28-35.
4. Mendez-Eastman S. Guidelines for using negative pressure wound therapy. Adv Skin Wound Care 2001;14:314-22.
5. Phillips TJ, et al. Effect of chronic wound fluid on fibroblasts. J Wound Care 1998;7:527-30.

on several factors. Some factors are related to the type of wound
and whether it needs removal of edema fluid containing a high
bacterial burden, facilitation of granulation tissue growth and/or
contraction, or promotion of flap or graft adherence to the
wound base. Given the FDA’s indications for NPWT, the exclusive manufacturer of the only NPWT device in the United States
(Vacuum-Assisted Closure, [V.A.C.]; Kinetic Concepts, Inc
[KCI], San Antonio, TX) further delineates recommended
guidelines for 7 wound categories to be managed with their
NPWT device, including acute/traumatic wounds, surgical
wound dehiscence, pressure ulcers, chronic ulcers (diabetic,
arterial, vascular), meshed grafts, fresh flaps, and compromised
flaps.2 The recommended guidelines encompass the selection of
228
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the initial and subsequent operation mode (whether it be continuous or intermittent), selection of the target suction pressure
for polyurethane and PVA foams, and the time interval between
foam dressing changes.
For more information about NPWT treatment parameters in
the management of wounds, see “Guidelines for Using
Negative Pressure Wound Therapy”by Susan Mendez-Eastman,
RN, CWCN, CPSN, published in the November/December
2001 issue of Advances in Skin & Wound Care.2 ●
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